Risk stratification of elderly patients with acute pulmonary embolism

European Journal of Clinical Investigation Jul 03, 2019

Klingenberg R, et al. - Through a prospective multicenter SWITCO65+ study involving 214 patients aged ≥ 65 years with a new submassive pulmonary embolism (PE), researchers assessed how combining high-sensitivity cardiac Troponin T (hs-cTnT), NT-pro-B-type natriuretic peptide (NT-proBNP) and high-sensitivity C-reactive protein (hs-CRP) could enhance risk stratification of patients with PE beyond the PESI risk score. Unlike hs-CRP, participants in the highest quartile had a greater risk of death through the first 6 months for hs-cTnT and a trend for NT-proBNP as that with the lowest quartile. Further, the PESI risk score had the greatest prognostic accuracy for 6-month mortality—exceeding hs-cTnT, NT-proBNP and hs-CRP, respectively. However, no clinically relevant effect on risk stratification of the combination of all three biomarkers was evident when they were added to the PESI risk score. Hence, 6-month mortality could be projected by the PESI risk score alone in older patients.

Go to Original

Sign-up to continue reading. It is free & takes less than 2 mins

  • 45 lakhs+ doctors trust M3 globally

  • Nonloggedininfinity icon
    Free & unlimited access to original articles and quizzes
  • Nonloggedinlock icon
    Secure: we never sell your data
This article is only available to members. Are you a doctor? Click here to signup for free.
M3 app logo
Choose easy access to M3 India from your mobile!

M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen